Identification of a homozygous deletion at 8p12-21 in a human prostate cancer xenograft

被引:0
|
作者
Van Alewijk, DC
Van Der Weiden, MM
Eussen, BJ
Van Den Andel-Thijssen, LD
Ehren-Van Eekelen, CC
König, JJ
Van Steenbrugge, GJ
Dinjens, WN
Trapman, J
机构
[1] Erasmus Univ, Dept Pathol, NL-3000 DR Rotterdam, Netherlands
[2] Erasmus Univ, Dept Clin Genet, NL-3000 DR Rotterdam, Netherlands
[3] Erasmus Univ, Dept Urol, NL-3000 DR Rotterdam, Netherlands
来源
GENES CHROMOSOMES & CANCER | 1999年 / 24卷 / 02期
关键词
D O I
10.1002/(SICI)1098-2264(199902)24:2<119::AID-GCC4>3.0.CO;2-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
One of the most frequent genetic abnormalities in prostate cancer is loss of the complete or part of the short arm of chromosome 8, indicating the localization of one or more tumor suppressor genes on this chromosomal arm. Using allelotyping, a frequently deleted region in prostate cancer in a genetic interval of approximately 17 cM between sequence tagged sites D8S87 and D8S133 at chromosome arm 8p12-21 was previously detected. A detailed physical map of this region is now available. Using known and novel polymorphic and nonpolymorphic sequence tagged sites in this interval, a search for homozygous deletions in DNAs from 14 prostate cancer-derived cell lines and xenografts was carried out. In DNA from xenograft PC133, the presence of a small homozygously deleted region of 730-1,320 kb was unambiguously established. At one site, the deletion disrupts the Werner syndrome gene. Data from allelotyping were confirmed and extended by fluorescence in situ hybridization analysis of PC133 chromosome spreads using centromere, YAC, and PAC chromosome 8 probes. (C) 1999 Wiley-Liss, Inc.
引用
收藏
页码:119 / 126
页数:8
相关论文
共 50 条
  • [1] Frequent germline deletion polymorphism of chromosomal region 8p12-p21 identified as a recurrent homozygous deletion in human tumors
    Ryu, B
    Song, J
    Sohn, T
    Hruban, RH
    Kern, SE
    GENOMICS, 2001, 72 (01) : 108 - 112
  • [2] Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21
    Vocke, CD
    Pozzatti, RO
    Bostwick, DG
    Florence, CD
    Jennings, SB
    Strup, SE
    Duray, PH
    Liotta, LA
    EmmertBuck, MR
    Linehan, WM
    CANCER RESEARCH, 1996, 56 (10) : 2411 - 2416
  • [3] HOMOZYGOUS DELETION AND FREQUENT ALLELIC LOSS OF CHROMOSOME-8P22 LOCI IN HUMAN PROSTATE-CANCER
    BOVA, GS
    CARTER, BS
    BUSSEMAKERS, MJG
    EMI, M
    FUJIWARA, Y
    KYPRIANOU, N
    JACOBS, SC
    ROBINSON, JC
    EPSTEIN, JI
    WALSH, PC
    ISAACS, WB
    CANCER RESEARCH, 1993, 53 (17) : 3869 - 3873
  • [4] ALLELIC LOSS ON CHROMOSOME 8P12-21 IN MICRODISSECTED PROSTATIC INTRAEPITHELIAL NEOPLASIA
    EMMERTBUCK, MR
    VOCKE, CD
    POZZATTI, RO
    DURAY, PH
    JENNINGS, SB
    FLORENCE, CD
    ZHUANG, ZP
    BOSTWICK, DG
    LIOTTA, LA
    LINEHAN, WM
    CANCER RESEARCH, 1995, 55 (14) : 2959 - 2962
  • [5] Identification of 12p as a region of frequent deletion in advanced prostate cancer
    Kibel, AS
    Schutte, M
    Kern, SE
    Isaacs, WB
    Bova, GS
    CANCER RESEARCH, 1998, 58 (24) : 5652 - 5655
  • [6] Homozygous and frequent deletion of proximal 8p sequences in human prostate cancers: Identification of a potential tumor suppressor gene site
    Prasad, MA
    Trybus, TM
    Wojno, KJ
    Macoska, JA
    GENES CHROMOSOMES & CANCER, 1998, 23 (03): : 255 - 262
  • [7] Physical mapping of chromosome 8p22 markers and their homozygous deletion in a metastatic prostate cancer
    Bova, GS
    MacGrogan, D
    Levy, A
    Pin, SS
    Bookstein, R
    Isaacs, WB
    GENOMICS, 1996, 35 (01) : 46 - 54
  • [8] Peculiar structure and location of 9p21 homozygous deletion breakpoints in human cancer cells
    Florl, AR
    Schulz, WA
    GENES CHROMOSOMES & CANCER, 2003, 37 (02): : 141 - 148
  • [9] Identification of a region of homozygous deletion on 8p22–23.1 in medulloblastoma
    Xiao-lu Yin
    Jesse Chung-sean Pang
    Ho-keung Ng
    Oncogene, 2002, 21 : 1461 - 1468
  • [10] Identification of a region of homozygous deletion on 8p22-23.1 in medulloblastoma
    Yin, XL
    Pang, JCS
    Ng, HK
    ONCOGENE, 2002, 21 (09) : 1461 - 1468